SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001213900-24-052877
Filing Date
2024-06-14
Accepted
2024-06-14 16:05:56
Documents
4
Effectiveness Date
2024-06-14

Document Format Files

Seq Description Document Type Size
1 REGISTRATION STATEMENT ea0207834-s8_tffpharma.htm S-8 66640
2 OPINION AND CONSENT OF GREENBERG TRAURIG, LLP ea020783401ex5-1_tffpharma.htm EX-5.1 7297
3 CONSENT OF MARCUM LLP ea020783401ex23-1_tffpharma.htm EX-23.1 2988
4 FILING FEE TABLE ea020783401ex-fee_tffpharma.htm EX-FILING FEES 11053
  Complete submission text file 0001213900-24-052877.txt   89006
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-280214 | Film No.: 241044732
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)